Pfizer Unit Can't End Skelaxin Pay-For-Delay Row In Pa.
A Pennsylvania judge has rejected a request by Pfizer Inc. unit King Pharmaceuticals Inc. and Mutual Pharmaceutical Co. Inc. to throw out litigation launched by generics maker SigmaPharm Inc. alleging the...To view the full article, register now.
Already a subscriber? Click here to view full article